参考文献
[1] Wu J, You J, Wang S, et al. Insights into the activation and inhibition of angiotensin II type 1 receptor in the mechanically loaded heart[J]. Circ J, 2014, 78(6): 1283⁃1289. DOI: 10.1253 /
circj.CJ⁃14⁃0470.
[2] Te Riet L, van Esch JH, Roks AJ, et al. Hypertension:renin⁃angiotensin⁃aldosterone system alterations[J].Circ Res, 2015, 116(6):960⁃975. DOI:10.1161/CIRCRESAHA.116.303587.
[3] Hansen DE, Cahill PD, DeCampli WM, et al. Valvular⁃ventricular interaction: importance of the mitral apparatus in canine left ventricular systolic performance[J].Circulation,1986, 73(6):1310⁃1320.
[4] Hansen DE, Sarris GE, Niczyporuk MA, et al. Physiologic role of the mitral apparatus in left ventricular regional mechanics, contraction synergy, and global systolic performance[J].J Thorac
Cardiovasc Surg,1989,97(4):521⁃533.
[5] Sarris GE, Cahill PD, Hansen DE, et al. Restoration of left ventricular systolic performance after reattachment of the mitral chordae tendineae. The importance of valvular⁃ventricular interaction[J]. J Thorac Cardiovasc Surg, 1988,95(6):969⁃979.
[6] You J, Wu J, Zhang Q, et al.Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload[J].Am J Physiol Heart Circ Physiol, 2018, 314(3): H552⁃H562. DOI:10.1152/ajpheart.00212.2017.
[7] Houser SR, Margulies KB, Murphy AM, et al.Animal models of heart failure: a scientific statement from the American Heart Association[J].Circ Res, 2012,111(1):131⁃150. DOI: 10.1161/RES.0b013e3182582523.
[8] Shimizu I, Minamino T.Physiological and pathological cardiac hypertrophy[J].J Mol Cell Cardiol,2016,97:245⁃62.DOI:10.1016/j.yjmcc.2016.06.001.
[9] Bernardo BC, Weeks KL, Pretorius L,et al.Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies[J]. Pharmacol
Ther, 2010, 128(1): 191⁃227. DOI: 10.1016 / j. pharmthera. 2010. 04.005.
[10] Mohamed BA, Schnelle M, Khadjeh S, et al. Molecular and structural transition mechanisms in long⁃term volume overload [J].Eur J Heart Fail, 2016,18(4):362⁃371. DOI:10.1002/ejhf.465.
[11] Toischer K1, Rokita AG, Unsöld B, et al. Differential cardiac remodeling in preload versus afterload[J].Circulation,2010,122 (10):993⁃1003. DOI:10.1161/CIRCULATIONAHA.110.943431.
[12] Champetier S, Bojmehrani A, Beaudoin J,et al..Gene profiling of left ventricle eccentric hypertrophy in aortic regurgitation in rats: rationale for targeting the beta⁃adrenergic and renin⁃angiotensin systems[J]. Am J Physiol Heart Circ Physiol, 2009,296(3):H669⁃H677. DOI:10.1152/ajpheart.01046.2008.
[13] Zhou YQ, Zhu SN, Foster FS, et al. Aortic regurgitation dramatically alters the distribution of atherosclerotic lesions and enhancesatherogenesis in mice[J].Arterioscler Thromb Vasc Biol, 2010,30(6):1181⁃1188. DOI:10.1161/ATVBAHA.110.204198.
[14] Huang J, Wu J, Wang S, et al.Ultrasound biomicroscopy validation of a murine model of cardiac hypertrophic preconditioning:comparison with a hemodynamic assessment[J].Am J Physiol Heart
Circ Physiol, 2017, 313(1): H138⁃H148. DOI: 10.1152 / ajpheart. 00004.2017.